Subscribe
Monday, September 21, 2026
28.2 C
Bengaluru
type here...
Subscribe
Exclusive ArticlesFeatured ArticleIndian Pharma Market Reports
6 min.Read

IPM November 2025 Sales Data Analysis

Anup Soans
By Anup Soans

IPM Momentum, Innovation Waves & the AQI-Driven Respiratory Surge — What Pharma Leaders Must Know Going Into 2026

By MedicinMan Editorial Team

The Indian Pharmaceutical Market (IPM) continues to demonstrate structural resilience and strong forward momentum. The latest PharmaTrac Acquaint – Nov’25 dataset provides rich insights into market drivers, therapy trends, competitive shifts and innovation flows that will define the industry’s direction in 2026.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

MedicinMan Market Intelligence

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...
MedicinMan Market Intelligence

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

0
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
MedicinMan Market Intelligence

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

0
Private equity does not pay a billion-dollar multiple simply...
MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...

Topics

MedicinMan Market Intelligence

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...
MedicinMan Market Intelligence

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

0
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
MedicinMan Market Intelligence

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

0
Private equity does not pay a billion-dollar multiple simply...
MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
spot_img

Related Articles

spot_imgspot_img
Previous article
Navigating India’s Diverging Health Landscape and Field Force Optimisation
Next article
Mounjaro to Orforglipro: Lilly’s $6 Billion Bet on the Next GLP‑1 Revolution

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

0
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

0
Private equity does not pay a billion-dollar multiple simply...

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk